About ATC 2020

Antibody Therapeutics Conference (ATC) is the most important annual and international conference held by Taiwan Antibody Association (TAA) for more than 6 years in Taiwan. ATC aims to provide an international forum for the field of antibody discovery, antibody engineering, antibody therapeutics development and commercialization. We aim to provide opportunities for the attendants to have good connections and to assist the training and advancement of students, postdoctoral fellows and other new members in the field, in part through sponsorship of international scientific meetings.

The COVID-19 outbreak in the last quarter of 2019 has posed a major impact on the global economy and society. The industry, government, academia and research institutes worldwide have all invested resources to actively develop diagnostic tests, therapeutic drugs and vaccines for COVID-19. To leverage all of achievement, this year Antibody Therapeutics Conference (ATC) will focus on sharing current development status and drug design concepts of antibody drugs for the treatment of COVID-19 hoping to inspire more ideas for the development of antibody drugs in the post-COVID-19 era on 29th October.